creases or decreases in central autonomic outflow from the vasomotor center, causing appropriate changes in heart rate and vascular resistance and leading to restoration of normal blood pressure. Thus, the system serves to defend against wide fluctuations in blood pressure.
Abnormalities in baroreflex function in both experimental12-'4 and human hypertension have been demonstrated in numerous studies, with hypertensive subjects exhibiting diminished baroreflex sensitivity compared with their normotensive counterparts. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] Although some studies indicate that this abnormality may be a consequence of elevated blood pressure,26,27 several lines of evidence suggest that the impairment in baroreflex function may have an etiologic role in hypertension. Studies performed in the 1930s and 1940s showed that in unanesthetized dogs and rabbits, the combined section of the carotid sinus and aortic nerves is followed by marked and persistent elevation in blood pressure. 28, 29 Also, destruction of baroreceptor inputs by lesions in the nucleus tractus solitarii in experimental animals results in fulminating hypertension and increased blood pres-sure variability produced by removal of baroreceptormediated tonic inhibition of central sympathetic outflow.30,31 Furthermore, acute increases in arterial pressure followed by sustained blood pressure elevation are observed after baroreceptor deafferentation in nonhuman primates. 32, 33 In addition, studies have shown that the impairment in baroreflex sensitivity may be present early in the course of, or precede the development of, hypertension. Abnormal baroreflex sensitivity has been shown to be diminished in the early phase of hypertension in spontaneously hypertensive rats'1134 as well as in borderline essential hypertension in humans. 19, 21 More recently, in Dahl salt-sensitive rats,35,36 diminished baroreflex sensitivity clearly preceded the onset of hypertension, also suggesting that the abnormality in baroreflex function may contribute to the development of elevated blood pressure. Moreover, in this genetic model of hypertension, the impairment in baroreflex sensitivity was therefore ultimately hereditary in origin.
To determine whether the impairment in baroreflex sensitivity has a hereditary component in human essential hypertension, we performed baroreflex function studies in hypertensive subjects stratified by the presence or absence of a family history of hypertension and in normotensive counterparts.
Methods

Subjects
We studied 64 adult male subjects divided into four groups based on Subjects with essential hypertension were consistently hypertensive (diastolic blood pressure greater than 90 mm Hg on at least three outpatient visits) and had no evidence of secondary hypertension or of hypertensive end-organ damage as assessed by history, physical examination, and screening laboratory tests (chest x-ray, ECG, hemogram, blood urea nitrogen, serum creatinine and electrolytes, urinalysis, and urinary catecholamine, metanephrine, and vanillylmandelic acid excretion). These subjects either had never been treated or had been off all antihypertensive medication for at least 2 weeks before study. The age range of these subjects was 25-60 years.
The normotensive controls were healthy subjects on no medication who had consistently normal blood pressure (diastolic blood pressure less than 90 mm Hg on at least three outpatient visits). The age range was 27-58 years.
Family history of hypertension was defined as a diastolic blood pressure greater than 90 mm Hg or blood pressure elevation requiring antihypertensive therapy occurring in a parent or sibling before the age of 60 years.37 Only subjects with a definite positive or negative family history were included.
Medical conditions known to affect baroreflex sensitivity such as diabetes mellitus38 and renal insufficiency39'40 were excluded with routine clinical chemistries including fasting blood glucose and serum creatinine determinations.
All subjects gave informed written consent, and the study was approved by the Human Subjects Committee of the University of California, San Diego.
Assessment of Baroreflex Sensitivity
Subjects were admitted to the special diagnostic and treatment unit of the San Diego Veterans Administration Medical Center for baroreflex function studies.
Continuous arterial pressure was measured either directly from the left brachial artery via an 18-gauge intra-arterial cannula connected to a Model 1280-C Hewlett-Packard pressure transducer or by noninvasively using the FINAPRES finger-cuff method,41 a technique in which accuracy has been validated for laboratory maneuvers that cause rapid and pronounced blood pressure changes, including baroreflex sensitivity testing.42-44 Arterial pressure and ECG lead V2 were recorded simultaneously on a two-channel Model 7702-B Hewlett-Packard recorder for analysis of beat-to-beat variations in blood pressure and heart rate. The direct intra-arterial method was used to evaluate 54 subjects, of whom 34 were FH+ and 20 were FH-, and the FINAPRES technique was used in the remaining 10 subjects, of whom five were FH+ and five were FH-. FH+ and FH-groups did not differ with regard to method of continuous arterial pressure monitoring (intra-arterial versus FINAPRES; X2=0.176, p=NS).
After measurement of baseline blood pressure and heart rate, assessment of baroreflex function was performed as previously described by our laboratory.25 '38'45-47 Baroreflex sensitivity to high-pressure stimulus. Highpressure (carotid sinus and aortic arch baroreceptor) baroreflex sensitivity was evaluated by recording cardiac slowing in response to acute phenylephrineinduced hypertension. 48 The subject inhaled three times from a gasfilled ampule of amyl nitrite broken under the nose.
(Results are expressed in milliseconds per millimeter of mercury.) The observer reading the baroreflex strips was blinded to family history status for each subject. Baroreflex sensitivity was assessed by amyl nitrite alone in the initial seven subjects studied and by both amyl nitrite and phenylephrine in all subsequent subjects.
Statistics
All results are expressed as mean+SEM. The results were analyzed by two-way analysis of variance (ANOVA) factoring for the effects of both blood pressure status (normotensive versus hypertensive) and family history of hypertension (positive versus negative). Simultaneous model multiple regression analysis was performed to assess the effect of several independent variables on baroreflex function. Multiple regression standardized coefficients49 were used to estimate the relative importance of these variables in predicting baroreflex sensitivity. Linear least-squares regression analysis followed by Student's t test for differences between two slopes50 was used to compare regression line slopes between FH+ and FH-groups. Statistical analyses were performed with SYSTAT statistical computing programs51 on an IBM-PC microcomputer.
Results Subject Characteristics Table 1 shows baseline subject characteristics for the four groups studied. Two-factor ANOVA demonstrated no significant differences in mean age among the four groups (p=NS for both blood pressure status and family history status effects). Mean baseline systolic blood pressure, diastolic blood pressure, and heart rate were significantly greater in hypertensives compared with normotensives but not different between FH-and FH+ groups. Body weight did not differ among the four groups. Racial distribution of the subjects was as follows: among normotensives, 19 were white and five were black, and among hypertensives, 28 were white and 12 were black (X2=0.262,p=NS); among FH-subjects, 21 were white and four were black, and among FH+ subjects, 26 were white and 13 were black (X2=1.542,p=NS).
Baroreflex Sensitivity Results
Results of baroreflex sensitivity to a low-pressure stimulus assessed by amyl nitrite inhalation are shown in Figure 1 . Two-factor ANOVA revealed significant effects on baroreflex sensitivity to amyl nitrite for both blood pressure status (F=8.927, p=0.004) and family history of hypertension (F=19.807, p<0.001). The interaction between blood pressure status and family history status was not significant (F= 1.138, p =0.290).
Results of baroreflex sensitivity to high-pressure stimulus assessed by phenylephrine bolus are shown in Figure 2 . Again, two-factor ANOVA revealed significant effects for both blood pressure status (F=6.924, p=0.011) and family history of hypertension (F=6.475, p=0.014) and no significant blood pressure status/family history status interaction (F=0.479, p =0.492).
Thus, when assessed by both low-and high-pressure stimuli, baroreflex sensitivity was significantly depressed in hypertensives compared with normotensives and in FH+ subjects compared with FH-subjects.
Barorefiex Sensitivity Predictors: Multiple Linear
Regression Analysis To control for the effects of several variables on baroreflex function, we evaluated these data by mul- tiple regression analysis, the results of which are shown in Tables 2 and 3 . Multiple regression analysis for baroreflex function assessed by amyl nitrite inhalation as the dependent variable (Table 2 ) revealed significant effects on baroreflex sensitivity for three of the independent variables tested -age, mean arterial pressure, and family history of hypertension -but not for race or body weight.
Multiple regression results for baroreflex function assessed by phenylephrine bolus as the dependent variable are shown in Table 3 . As in the case of baroreflex sensitivity to amyl nitrite, there was a significant effect for mean arterial pressure and family history of hypertension but not for age, race, or body weight.
Multiple regression standardized coefficients49 were greatest for family history of hypertension, indicating that family history status was the strongest unique predictor of baroreflex sensitivity assessed by both amyl nitrite and phenylephrine.
The combination of variables used in the multiple regression analyses predicted baroreflex sensitivity To investigate more closely the relation between baroreflex sensitivity (to amyl nitrite), age, and family history of hypertension, we analyzed regression line equations for the correlation of baroreflex sensitivity and age for both FH+ and FH-subjects. This analysis is shown in Figure 3 . Baroreflex sensitivity was significantly inversely correlated with age in FH-subjects (r=-0.679,p<0.001) but not in FH+ subjects (r= -0.261, p=0.109). The slope of the re- gression line for FH+ subjects was significantly less negative than the regression line slope of this relation for FH-subjects (b=-0.164 versus b=-0.764, p=0.002). Baroreflex sensitivity assessed by phenylephrine did not correlate with age in these subjects.
Discussion
Abnormalities in baroreflex function have been demonstrated in numerous studies in both experimental12-14 and humanl5-25 hypertension. Whereas the impairment in baroreflex sensitivity was initially thought to be the result of elevated arterial pressure and consequent reduced arterial distensibility,26'27 more recent studies have suggested that this abnormality might precede the onset of hypertension and contribute to its pathogenesis.
In agreement with previous studies,15-25 we found that baroreflex sensitivity to both high-and lowpressure stimuli was diminished in hypertensives compared with normotensive controls. Additionally, these results now demonstrate that baroreflex sensitivity is strongly influenced by the presence or absence of a family history of hypertension, suggesting that baroreflex function is, in part, genetically determined in humans. Moreover, the effect of heredity was independent of blood pressure, because within both the normotensive and hypertensive groups, FH-and FH+ subjects were matched with regard to blood pressure (Table 1) yet differed significantly with regard to baroreflex function (Figures 1 and 2) . The independent effect of heredity on baroreflex sensitivity was further documented by multiple regression analyses (Tables 2 and 3 ). After controlling for the effects of several variables, including age, mean arterial pressure, body weight, and race, the effect of family history of hypertension on baroreflex function assessed by both amyl nitrite and phenylephrine was highly significant. Indeed, examination of the standardized coefficients generated by the multiple regression analysis for both amyl nitrite inhalation and phenylephrine bolus (Tables 2 and 3) revealed that family history of hypertension was the strongest unique predictor of baroreflex sensitivity. A significant independent effect for blood pressure was also demonstrated. Thus, on the one hand, diminished baroreflex sensitivity appears, in part, to be a consequence of elevated arterial pressure, perhaps as a result of decreased arterial distensibility that accompanies blood pressure elevation. On the other hand, impaired baroreflex sensitivity is, in large part, inherited and might contribute to the propensity of those with familial hypertension to develop elevated blood pressure.
Multiple regression results also revealed a significant independent effect of age on baroreflex sensitivity assessed by amyl nitrite inhalation (Table 2 ). An independent effect of age on baroreflex function is well known and has been attributed to decreased arterial distensibility that occurs with aging.17"18'27 '52 Further examination (Figure 3) showed that the relation between baroreflex sensitivity and age was significant only for the FH-subjects. In addition, the slope of the regression line for this relation was significantly different in FH-subjects from that in FH+ subjects. Thus, in FH-subjects, baroreflex abnormalities may occur predominantly in association with aging, perhaps as a result of decreased arterial distensibility over time. On the other hand, in FH+ subjects, baroreflex sensitivity impairment is present at an earlier age, once again consistent with a hereditary influence on baroreflex function in this group. Although we did not find such an age effect for baroreflex sensitivity to phenylephrine bolus, previous studies have shown an influence of age on baroreflex sensitivity assessed by phenylephrine and another pressor, angiotensin.17"18,27 '52 Whereas impaired baroreflex function may contribute to or exacerbate hypertension in certain individuals, this abnormality itself is not sufficient to cause hypertension, because altered baroreflex sensitivity was found in some normotensive subjects (FH+ normotensives). However, diminished baroreflex sensitivity could interact with other genetic and environmental stimuli to give rise to blood pressure elevation. Indeed, essential hypertension is likely a heterogeneous and multifactorial disorder with contributions from several genetic loci, one or more of which may play a predominant role in a given individual. 53 Other phenotypic abnormalities that may be genetically determined and predispose subjects to hypertension include increased red blood cell sodium-lithium countertransport,54 decreased urinary kallikrein levels,55 and nonmodulation of the effects of the renin-angiotensin system.37 It will be of interest to determine whether these abnormalities as well as the impairment in baroreflex sensitivity are linked by a common anomaly and thus found in the same individuals or whether they contribute independently to elevated blood pressure.
Several reports in which baroreceptor denervation in experimental animals produced increases in blood pressure variability without affecting the overall level of blood pressure have questioned the importance of the impairment in baroreflex sensitivity in the pathogenesis of hypertension.56-58 Others In summary, the results of this study suggest that the impairment in baroreflex sensitivity in hypertension is, in large part, genetically determined and may be an important hereditary component in the pathogenesis of human essential hypertension.
